Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Latest News about Eli Lilly and Co

Recent news which mentions Eli Lilly and Co

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Weight loss drugs, Alzheimer's treatments and gene editing: Enormous firsts defined 2023 in pharma
Tags Pharmaceuticals Health & Science Amgen Inc
From CNBC.com News
Treasury yields dip slightly as Fed trajectory remains in focus
Tags Citigroup Inc Central Banks Central banking
From CNBC.com News
Treasury yields down slightly as recent trend continues
Tags Delta Air Lines Inc United Airlines Holdings Inc Breaking News: Markets
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Pfizer Inc 5 Things to Know Nike Inc
From CNBC.com News
The weight loss drug boom isn't over yet — here's what to expect in the year ahead
Tags US: News Eli Lilly and Co Novo Nordisk A/S
From CNBC.com News
Patients regain weight after stopping Eli Lilly's Zepbound, study says
Tags Health & Science Pharmaceuticals Novo Nordisk A/S
From CNBC.com News
Treasury yields inch higher ahead of Fed meeting
Tags US: News Johnson & Johnson U/S/ Markets
From CNBC.com News
Biden administration asserts power to seize drug patents in move to slash high prices
Tags Government and politics Politics Policy
From CNBC.com News
Cramer examines Tuesday's market 'mistakes,' points out underappreciated stocks
Tags U/S/ Markets Eli Lilly and Co Investing
From CNBC.com News
Eli Lilly weight loss drug Zepbound now available at pharmacies as rival Wegovy faces shortages
Tags Business News Biotech and Pharmaceuticals Biotechnology
From CNBC.com News
Cramer says the growing popularity of weight loss drugs brings new investing opportunities
Tags Tyson Foods Inc Business Investment Strategy
From CNBC.com News
Pfizer's twice-daily weight loss pill joins a long list of obesity drug flops
Tags Business Health care industry Abbott Laboratories
From CNBC.com News
Pfizer to discontinue twice-daily weight loss pill due to high rates of adverse side effects
Tags Business Health care industry Companies
From CNBC.com News
Novo Nordisk sues two pharmacies for allegedly selling tainted Wegovy, Ozempic knockoffs
Tags Business News Novo Nordisk A/S US: News
From CNBC.com News
Mounjaro is more effective than Ozempic for weight loss in overweight and obese adults, real world study says
Tags Biotech and Pharmaceuticals Biotechnology Science
From CNBC.com News
This key element of ESG investing could drive real change at companies and boost returns
Tags Microsoft Corp H/B/ Fuller Company Evercore Partners Inc
From CNBC.com News
Jim Cramer says insurance companies will pay for 'revolutionary' weight-loss drugs for their members
Tags stocks Stock Picks Markets
From CNBC.com News
Pfizer wants in on the weight loss drug market – and upcoming data will be crucial for its success
Tags Pfizer Inc Eli Lilly and Co US: News
From CNBC.com News
Cramer's week ahead: Consumer spending in the spotlight with retail earnings and a new price index
Tags Accenture PLC Monday/Com Ltd Investment strategy
From CNBC.com News
FDA approves Eli Lilly's tirzepatide for obesity, paving way for even wider use of blockbuster drug
Tags Pharmaceuticals Health & Science Social issues
From CNBC.com News
Eli Lilly says supply of blockbuster diabetes drug Mounjaro has improved in U.S.
Tags Biotechnology Biotech and Pharmaceuticals Business News
From CNBC.com News
Eli Lilly results top estimates on Mounjaro strength but slashes full-year profit outlook
Tags Biotech and Pharmaceuticals Biotechnology Business News
From CNBC.com News
Pfizer swings to quarterly loss due to Paxlovid, Covid vaccine write-offs
Tags Novo Nordisk A/S US: News Eli Lilly and Co
From CNBC.com News
5 things to know before the stock market opens Monday
Tags Apple Inc Pfizer Inc Walgreens Boots Alliance Inc
From CNBC.com News
Cramer's week ahead: Federal Reserve meeting, Apple and Eli Lilly earnings
Tags stocks Eaton Corporation PLC Markets
From CNBC.com News
Treasury yields continue retreat after 10-year slips back below 5%
Tags Bitcoin Moderna Inc World Markets
From CNBC.com News
Wall Street hikes forecasts for anti-obesity drug sales to $100 billion and beyond — A look at the numbers
Tags Investing Health & Science Breaking News: Investing
From CNBC.com News
Treasury yields rise again as 10-year hovers near 5%
Tags Central banking Citigroup Inc Central Banks
From CNBC.com News
Sanofi to offer insulin product for $35 to all Americans through GoodRx
Tags Goodrx Holdings Inc Health & Science Pharmaceuticals
From CNBC.com News
'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles
Tags Stock markets Weight loss diets Weight management
From CNBC.com News
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.